Neogen Corporation (NEOG) Releases Earnings Results, Reports EPS of $0.26 EPS

Neogen Corporation (NEOG) reported quarterly earnings results on Tuesday, Jul-19-2016. The company reported $0.26 EPS for the quarter. Analysts had a consensus estimate of $0.26. The company posted revenue of $90.10 million in the period, compared to analysts expectations of $86.11 million. The company’s revenue was up 14.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.25 EPS.

Neogen Corporation opened for trading at $56.14 and hit $57.05 on the upside on Monday, eventually ending the session at $56.77, with a gain of 1.43% or 0.8 points. The heightened volatility saw the trading volume jump to 1,95,177 shares. Company has a market cap of $2,130 M.

In a different news, on May 23, 2016, Richard T Crowder (director) sold 27,250 shares at $48.05 per share price. According to the SEC, on May 12, 2016, Jack C Parnell (director) sold 4,000 shares at $49.17 per share price. On Mar 29, 2016, Steven J. Quinlan (CFO) purchased 2,236 shares at $44.73 per share price, according to the Form-4 filing with the securities and exchange commission.

Neogen Corporation develops manufactures and markets a diverse line of products dedicated to food and animal safety. The Company has two segments: Food Safety and Animal Safety. The Food Safety segment is engaged in the development production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins foodborne bacteria allergens and levels of general sanitation. The Animal Safety segment is engaged in the development production and marketing of products dedicated to animal safety including a complete line of consumable products marketed to veterinarians and animal health product distributors. It also provides genomic identification and related interpretive bioinformatics services. Additionally the Animal Safety segment produces and markets rodenticides disinfectants and insecticides to assist in control of rodents insects and disease in and around agricultural food production and other facilities.

Neogen Corporation

Leave a Reply

Neogen Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Neogen Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.